αTIGIT-IL2 achieves tumor regression by promoting tumor-infiltrating regulatory T cell fragility in mouse models

Journal:

Nature Communications

Published:

2025-10-17

DOI:

10.1038/s41467-025-64296-z

Affiliations:

8

Authors:

13

Go to article

Institutions	Authors	Share
State Key Laboratory of Immune Response and Immunotherapy, China	8.166667	0.63
Hefei TG ImmunoPharma, China	1.416667	0.11
University of Science and Technology of China (USTC), China	1.000000	0.08
Shanghai Tongren Hospital, SJTU, China	1.000000	0.08
Shenzhen Institutes of Advanced Technology (SIAT), CAS, China	0.666667	0.05
Fudan University, China	0.500000	0.04
Fudan University Shanghai Cancer Center (FUSCC), China	0.250000	0.02

Interested in Oncology and Carcinogenesis?